{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:11:21Z","timestamp":1793193081373,"version":"4.5.0"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["99-1-148-47998"],"award-info":[{"award-number":["99-1-148-47998"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jconrel.2022.07.023","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T17:53:52Z","timestamp":1659030832000},"page":"649-661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Polymeric nanoparticles for drug delivery in glioblastoma: State of the art and future perspectives"],"prefix":"10.1016","volume":"349","author":[{"given":"Fatemeh","family":"Madani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Sara","family":"Esnaashari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masood","family":"Khosravani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Adabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.07.023_bb0005","series-title":"Nanotherapy for Brain Tumor Drug Delivery","author":"Agrahari","year":"2021"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0010","first-page":"1423","article-title":"Primary brain tumors in adults","volume":"77","author":"Chandana","year":"2008","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0015","first-page":"5784","article-title":"Allelotype of human malignant astrocytoma","volume":"50","author":"Fults","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0020","first-page":"4225","article-title":"Preparation of curcumin-loaded PLGA nanoparticles and investigation of its cytotoxicity effects on human glioblastoma U87MG cells","volume":"9","author":"Arzani","year":"2019","journal-title":"Biointerface Res. Appl. Chem."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0025","article-title":"The versatile role of HuR in glioblastoma and its potential as a therapeutic target for a multi-pronged attack","volume":"114082","author":"Guha","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0030","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1517\/13543780903052764","article-title":"Glioblastoma multiforme: a review of where we have been and where we are going","volume":"18","author":"Adamson","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0035","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1158\/1055-9965.EPI-14-0275","article-title":"Epidemiologic and molecular prognostic review of glioblastoma","volume":"23","author":"Thakkar","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0040","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1124\/pr.117.014944","article-title":"Current challenges and opportunities in treating glioblastoma","volume":"70","author":"Shergalis","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0045","article-title":"Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: nanomedicine approaches to improve their efficacy","volume":"119283","author":"Aparicio-Blanco","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/bjp.2008.260","article-title":"Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2","volume":"155","author":"Regina","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0055","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1016\/j.biomaterials.2011.02.044","article-title":"Angiopep-conjugated poly (ethylene glycol)-co-poly (\u03b5-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma","volume":"32","author":"Xin","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0060","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.20048","article-title":"Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles","volume":"109","author":"Steiniger","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0065","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1021\/am5092165","article-title":"Temozolomide nanoparticles for targeted glioblastoma therapy","volume":"7","author":"Fang","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0070","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.2165\/00003495-200565170-00007","article-title":"Docetaxel","volume":"65","author":"Williamson","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0075","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00003495-200868040-00009","article-title":"Bevacizumab","volume":"68","author":"McCormack","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0080","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2147\/TCRM.S58289","article-title":"Bevacizumab for glioblastoma","volume":"11","author":"Narita","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0085","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.3390\/molecules26144127","article-title":"Organic Nanocarriers for bevacizumab delivery: an overview of development, characterization and applications","volume":"26","author":"Alves","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0090","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3174\/ajnr.A2054","article-title":"Cetuximab (erbitux)","volume":"31","author":"Bou-Assaly","year":"2010","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0095","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s13346-020-00824-2","article-title":"Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route","volume":"10","author":"Ferreira","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0100","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s13346-020-00713-8","article-title":"A novel strategy for glioblastoma treatment combining alpha-cyano-4-hydroxycinnamic acid with cetuximab using nanotechnology-based delivery systems","volume":"10","author":"Ferreira","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120714","article-title":"Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system","volume":"603","author":"Ferreira","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0110","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/annonc\/mdf337","article-title":"Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity","volume":"13","author":"Xu","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3390\/pharmaceutics13040541","article-title":"Development and optimization of irinotecan-loaded PCL nanoparticles and their cytotoxicity against primary high-grade glioma cells","volume":"13","author":"Mahmoud","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fneng.2013.00007","article-title":"The blood-brain barrier: an engineering perspective","volume":"6","author":"Wong","year":"2013","journal-title":"Front. Neuroeng."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12987-019-0150-9","article-title":"Claudin-12 is not required for blood\u2013brain barrier tight junction function","volume":"16","author":"Dias","year":"2019","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0130","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood\u2013brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0135","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s13346-019-00679-2","article-title":"Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme","volume":"10","author":"Jena","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.15171\/bi.2016.30","article-title":"Blood-brain barrier transport machineries and targeted therapy of brain diseases","volume":"6","author":"Barar","year":"2016","journal-title":"BioImpacts: BI"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0145","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1134\/S0006297914090089","article-title":"Intracellular transport based on actin polymerization","volume":"79","author":"Khaitlina","year":"2014","journal-title":"Biochem. Mosc."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0150","series-title":"Polymer Nanoparticles for Smart Drug Delivery","author":"Bennet","year":"2014"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0155","first-page":"257","article-title":"Polymer nanoparticles for smart drug delivery","author":"Bennet","year":"2014","journal-title":"Appl. Nanotechnol. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/1440-1681.13034","article-title":"Omega-3 fatty acids in coronary heart disease: recent updates and future perspectives","volume":"46","author":"Ajith","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0165","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1021\/acs.molpharmaceut.9b01215","article-title":"Nose-to-brain delivery of cancer-targeting paclitaxel-loaded nanoparticles potentiates antitumor effects in malignant glioblastoma","volume":"17","author":"Ullah","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0170","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12247-018-9318-0","article-title":"Optimization of noscapine-loaded mPEG-PLGA nanoparticles and release study: a response surface methodology approach","volume":"13","author":"Esnaashari","year":"2018","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0175","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1208\/s12249-020-01710-3","article-title":"A combinational approach towards treatment of breast cancer: an analysis of noscapine-loaded polymeric nanoparticles and doxorubicin","volume":"21","author":"Esnaashari","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/10837450.2018.1551901","article-title":"Preparation and characterization of angiopep-2 functionalized ginsenoside-Rg3 loaded nanoparticles and the effect on C6 glioma cells","volume":"25","author":"Su","year":"2020","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0185","article-title":"Development and in vitro evaluation of temozolomide-loaded PLGA nanoparticles in a thermoreversible hydrogel system for local administration in glioblastoma multiforme","volume":"57","author":"Sayiner","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0190","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/annonc\/mdh003","article-title":"Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumors","volume":"15","author":"Vera","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0195","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/02652048.2020.1729885","article-title":"How subtle differences in polymer molecular weight affect doxorubicin-loaded PLGA nanoparticles degradation and drug release","volume":"37","author":"Kumskova","year":"2020","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0200","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2147\/IJN.S231407","article-title":"Improvement of paclitaxel-associated adverse reactions (ADRs) via the use of Nano-based drug delivery systems: a systematic review and network meta-analysis","volume":"15","author":"Chou","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0205","first-page":"19","article-title":"Preparation of methotrexate loaded PLGA nanoparticles coated with PVA and Poloxamer188","volume":"3","author":"Madani","year":"2018","journal-title":"Nanomed. Res. J."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118729","article-title":"Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells","volume":"573","author":"Vandghanooni","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0215","article-title":"Formulation and characterization of noscapine-loaded polycaprolactone nanoparticles","volume":"13","author":"Kumar","year":"2019","journal-title":"Asian J. Pharm."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0220","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1124\/jpet.119.258152","article-title":"Nose-to-brain delivery","volume":"370","author":"Wang","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0225","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11095-019-2662-z","article-title":"Increased nose-to-brain delivery of melatonin mediated by polycaprolactone nanoparticles for the treatment of glioblastoma","volume":"36","author":"de Oliveira Junior","year":"2019","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0230","first-page":"434","article-title":"Curcumin encapsulated into methoxy poly (ethylene glycol) poly (\u03b5-caprolactone) nanoparticles increases cellular uptake and neuroprotective effect in glioma cells","volume":"83","author":"Marslin","year":"2017","journal-title":"Planta Med."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0235","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1021\/acsomega.0c05848","article-title":"Transferrin: biology and use in receptor-targeted Nanotherapy of gliomas","volume":"6","author":"Koneru","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112033","article-title":"Docetaxel-loaded folate-modified TPGS-transfersomes for glioblastoma multiforme treatment","volume":"124","author":"Luiz","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0245","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s42247-019-00033-9","article-title":"Preparation of transferrin-conjugated poly-\u03b5-caprolactone nanoparticles and delivery of paclitaxel to treat glioblastoma across blood\u2013brain barrier","volume":"2","author":"Heggannavar","year":"2019","journal-title":"Emerg. Mater."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0250","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jbm.a.36827","article-title":"Sustained release of silibinin-loaded chitosan nanoparticle induced apoptosis in glioma cells","volume":"108","author":"Alipour","year":"2020","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120722","article-title":"Effect of paclitaxel\/etoposide co-loaded polymeric nanoparticles on tumor size and survival rate in a rat model of glioblastoma","volume":"604","author":"Maleki","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0260","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4314\/tjpr.v16i8.3","article-title":"Preparation of N, N, N-trimethyl chitosan-functionalized retinoic acid-loaded lipid nanoparticles for enhanced drug delivery to glioblastoma","volume":"16","author":"Liu","year":"2017","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0265","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/jcp.27019","article-title":"Preparation of superparamagnetic iron oxide\/doxorubicin loaded chitosan nanoparticles as a promising glioblastoma theranostic tool","volume":"234","author":"Gholami","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0270","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2147\/IJN.S152461","article-title":"Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs)","volume":"13","author":"Shevtsov","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0275","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.carbpol.2016.09.085","article-title":"Lactoferrin-coated polysaccharide nanoparticles based on chitosan hydrochloride\/hyaluronic acid\/PEG for treating brain glioma","volume":"157","author":"Xu","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2019.111773","article-title":"Apoptotic induction and anti-metastatic activity of eugenol encapsulated chitosan nanopolymer on rat glioma C6 cells via alleviating the MMP signaling pathway","volume":"203","author":"Li","year":"2020","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0285","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pdpdt.2018.06.026","article-title":"Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line","volume":"23","author":"Jamali","year":"2018","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119076","article-title":"Combination of paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration","volume":"578","author":"Caban-Toktas","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0295","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.msec.2018.10.094","article-title":"Targeted delivery of etoposide, carmustine and doxorubicin to human glioblastoma cells using methoxy poly (ethylene glycol)-poly (\u03b5-caprolactone) nanoparticles conjugated with wheat germ agglutinin and folic acid","volume":"96","author":"Kuo","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0300","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3109\/10717544.2014.948643","article-title":"Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery","volume":"23","author":"Alex","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0305","doi-asserted-by":"crossref","first-page":"10047","DOI":"10.2147\/IJN.S231167","article-title":"Verteporfin-loaded anisotropic poly (beta-amino ester)-based micelles demonstrate brain cancer-selective cytotoxicity and enhanced pharmacokinetics","volume":"14","author":"Shamul","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0310","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1007\/s13277-015-4106-7","article-title":"Enhanced anti-tumor effects of doxorubicin on glioma by entrapping in polybutylcyanoacrylate nanoparticles","volume":"37","author":"Zhang","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0315","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/ph13030044","article-title":"Preparation, characterization, and evaluation of cisplatin-loaded polybutylcyanoacrylate nanoparticles with improved in vitro and in vivo anticancer activities","volume":"13","author":"Ghaferi","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0320","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1021\/acs.bioconjchem.5b00379","article-title":"Mammary-derived growth inhibitor targeting peptide-modified PEG\u2013PLA nanoparticles for enhanced targeted glioblastoma therapy","volume":"26","author":"Feng","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0325","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.colsurfb.2018.02.048","article-title":"pH driven precipitation of quisinostat onto PLA-PEG nanoparticles enables treatment of intracranial glioblastoma","volume":"166","author":"Householder","year":"2018","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0330","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.2147\/IJN.S257459","article-title":"Transferrin receptor-targeted PEG-PLA polymeric micelles for chemotherapy against glioblastoma multiforme","volume":"15","author":"Sun","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0335","first-page":"862581","article-title":"Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy","author":"Gregory","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0340","series-title":"Nanotechnology-based Targeted Drug Delivery Systems for Brain Tumors","first-page":"169","article-title":"Biopolymeric nanoparticles for targeted drug delivery to brain tumors","author":"Elzoghby","year":"2018"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0345","doi-asserted-by":"crossref","DOI":"10.1590\/s2175-97902019000318306","article-title":"Synergistic effect of microRNA and albumin-bound nanoparticles for inhibition of glioblastoma cancer cell proliferation","volume":"56","author":"Shariatnasery","year":"2020","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0350","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijbiomac.2018.06.059","article-title":"Role of modification route for zinc oxide nanoparticles on protein structure and their effects on glioblastoma cells","volume":"118","author":"Altunbek","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0355","article-title":"Strategies for surface modification of gelatin-based nanoparticles","volume":"183","author":"Saber","year":"2019","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0360","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.matlet.2011.10.042","article-title":"Blood\u2013brain barrier transport of tat peptide and polyethylene glycol decorated gelatin\u2013siloxane nanoparticle","volume":"68","author":"Tian","year":"2012","journal-title":"Mater. Lett."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0365","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.reactfunctpolym.2017.09.008","article-title":"Preparation and characterization of cardamom extract-loaded gelatin nanoparticles as effective targeted drug delivery system to treat glioblastoma","volume":"120","author":"Nejat","year":"2017","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0370","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.2147\/IJN.S161163","article-title":"Lactoferrin-and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy","volume":"13","author":"Zhang","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0375","doi-asserted-by":"crossref","first-page":"234","DOI":"10.22159\/ijap.2018v10i6.28004","article-title":"Carmustine loaded lactoferrin nanoparticles demonstrates an enhanced antiproliferative activity against glioblastoma in vitro","volume":"10","author":"Athmakur","year":"2018","journal-title":"Int. J. App. Pharm."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-06888-4","article-title":"Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433)","volume":"7","author":"Kumari","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0385","article-title":"Paclitaxel\/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: formulation development and in vitro antitumor activity evaluation","volume":"117943","author":"Madani","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0390","first-page":"1","article-title":"Combination and co-delivery of methotrexate and curcumin: preparation and in vitro cytotoxic investigation on glioma cells","author":"Mujokoro","year":"2019","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0395","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/jcm8030367","article-title":"Synergistic action of gefitinib and GSK41364A simultaneously loaded in ratiometrically-engineered polymeric nanoparticles for glioblastoma multiforme","volume":"8","author":"Velpurisiva","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0400","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/IJN.S116367","article-title":"Synergistic anti-glioma effect of a coloaded nano-drug delivery system","volume":"12","author":"Xu","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0405","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.2147\/IJN.S243878","article-title":"Combined delivery of Temozolomide and siPLK1 using targeted nanoparticles to enhance Temozolomide sensitivity in glioma","volume":"15","author":"Shi","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0410","doi-asserted-by":"crossref","first-page":"9737","DOI":"10.12659\/MSM.918899","article-title":"Multifunctional polyethylene glycol (PEG)-poly (lactic-co-glycolic acid)(PLGA)-based nanoparticles loading doxorubicin and Tetrahydrocurcumin for combined Chemoradiotherapy of glioma","volume":"25","author":"Zhang","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0415","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1166\/jnn.2014.8757","article-title":"Functional nanoparticles in targeting glioma diagnosis and therapies","volume":"14","author":"Li","year":"2014","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0420","doi-asserted-by":"crossref","first-page":"8583","DOI":"10.1021\/nn402662d","article-title":"Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood\u2013brain tumor barrier","volume":"7","author":"Miura","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0425","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1021\/mp400751g","article-title":"RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration","volume":"11","author":"Gao","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0430","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cbpa.2006.03.015","article-title":"Aptamer therapeutics advance","volume":"10","author":"Lee","year":"2006","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0435","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.3390\/ijms18122576","article-title":"Aptamers and glioblastoma: their potential use for imaging and therapeutic applications","volume":"18","author":"Hays","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117907","article-title":"pH-controlled nucleolin targeted release of dual drug from chitosan-gold based aptamer functionalized nano drug delivery system for improved glioblastoma treatment","volume":"262","author":"Sathiyaseelan","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0445","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3390\/cancers12082173","article-title":"The role of RNA and dna aptamers in glioblastoma diagnosis and therapy: a systematic review of the literature","volume":"12","author":"Nuzzo","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0450","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.biomaterials.2012.10.048","article-title":"F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery","volume":"34","author":"Hu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0455","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijpharm.2018.11.014","article-title":"Toxicological study of doxorubicin-loaded PLGA nanoparticles for the treatment of glioblastoma","volume":"554","author":"Pereverzeva","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0460","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3389\/fphar.2020.00558","article-title":"Enhanced anti-glioma efficacy by Borneol combined with CGKRK-modified paclitaxel self-assembled redox-sensitive nanoparticles","volume":"11","author":"Lv","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.119002","article-title":"Borneol and poly (ethylene glycol) dual modified BSA nanoparticles as an itraconazole vehicle for brain targeting","volume":"575","author":"Zhang","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0470","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.xphs.2018.11.046","article-title":"Pep-1&borneol\u2013bifunctionalized carmustine-loaded micelles enhance anti-glioma efficacy through tumor-targeting and BBB-penetrating","volume":"108","author":"Guo","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118485","article-title":"Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol","volume":"567","author":"Meng","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0480","first-page":"363","article-title":"Lipid-albumin nanoassemblies co-loaded with borneol and paclitaxel for intracellular drug delivery to C6 glioma cells with P-gp inhibition and its tumor targeting","volume":"10","author":"Tang","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0485","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ddr.21545","article-title":"Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems","volume":"80","author":"Narmani","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0490","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biocel.2019.01.010","article-title":"Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma","volume":"108","author":"Minaei","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0495","doi-asserted-by":"crossref","first-page":"77","DOI":"10.24198\/idjp.v1i3.23613","article-title":"Nanoparticles targeted drug delivery system via epidermal growth factor receptor","volume":"1","author":"Rusdin","year":"2019","journal-title":"Indo. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0500","article-title":"Cetuximab conjugated temozolomide-loaded poly (lactic-co-glycolic acid) nanoparticles for targeted nanomedicine in EGFR overexpressing cancer cells","volume":"60","author":"Duwa","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0505","doi-asserted-by":"crossref","first-page":"189","DOI":"10.7150\/thno\/v01p0189","article-title":"Integrin targeted delivery of chemotherapeutics","volume":"1","author":"Chen","year":"2011","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0510","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3892\/ijo.2012.1708","article-title":"A small-molecule RGD-integrin antagonist inhibits cell adhesion, cell migration and induces anoikis in glioblastoma cells","volume":"42","author":"Russo","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0515","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jgm.2726","article-title":"Glutathione-sensitive RGD-poly (ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery","volume":"15","author":"Lei","year":"2013","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0520","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.msec.2016.03.062","article-title":"Design, preparation and characterization of cyclic RGDfK peptide modified poly (ethylene glycol)-block-poly (lactic acid) micelle for targeted delivery","volume":"64","author":"Li","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0525","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1039\/C6BM00708B","article-title":"Multifunctional PEI-entrapped gold nanoparticles enable efficient delivery of therapeutic siRNA into glioblastoma cells","volume":"5","author":"Kong","year":"2017","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0530","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/17425247.3.3.311","article-title":"Nanoparticle\u2013aptamer bioconjugates for cancer targeting","volume":"3","author":"Farokhzad","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0535","doi-asserted-by":"crossref","first-page":"7766","DOI":"10.1039\/C6TB02564A","article-title":"Aptamer application in targeted delivery systems for diagnosis and treatment of breast cancer","volume":"4","author":"Shahdordizadeh","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0540","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/aps.2017.20","article-title":"Molecular tumor targeting of gelonin by fusion with F3 peptide","volume":"38","author":"Ham","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0545","doi-asserted-by":"crossref","first-page":"17817","DOI":"10.1021\/acsami.6b04442","article-title":"Tumor-homing and penetrating peptide-functionalized photosensitizer-conjugated PEG-PLA nanoparticles for chemo-photodynamic combination therapy of drug-resistant cancer","volume":"8","author":"Feng","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0550","article-title":"Nanoparticles for brain drug delivery","volume":"2013","author":"Masserini","year":"2013","journal-title":"Int. Sch. Res. Notices"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0555","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejpb.2009.09.003","article-title":"Drug delivery to the brain using surfactant-coated poly (lactide-co-glycolide) nanoparticles: influence of the formulation parameters","volume":"74","author":"Gelperina","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0560","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1111\/jcmm.13695","article-title":"Mechanisms of enhanced antiglioma efficacy of polysorbate 80-modified paclitaxel-loaded PLGA nanoparticles by focused ultrasound","volume":"22","author":"Li","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0565","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1080\/02652048.2020.1809724","article-title":"Preparation and characterization of lutein loaded folate conjugated polymeric nanoparticles","volume":"37","author":"Bolla","year":"2020","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0570","first-page":"6000","article-title":"Dual-targeting Temozolomide loaded in folate-conjugated magnetic triblock copolymer nanoparticles to improve the therapeutic efficiency of rat brain gliomas, ACS biomater","volume":"5","author":"Afzalipour","year":"2019","journal-title":"Sci. Eng."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0575","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2007.06.019","article-title":"Development of bionanocapsules targeting brain tumors","volume":"122","author":"Tsutsui","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0580","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s10495-015-1168-3","article-title":"Hyperthermia: an effective strategy to induce apoptosis in cancer cells","volume":"20","author":"Ahmed","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2021.126648","article-title":"GRGDS-conjugated and curcumin-loaded magnetic polymeric nanoparticles for the hyperthermia treatment of glioblastoma cells","volume":"622","author":"Senturk","year":"2021","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0590","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","article-title":"Photodynamic therapy","volume":"90","author":"Dougherty","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0595","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/153303460500400308","article-title":"A review of progress in clinical photodynamic therapy","volume":"4","author":"Huang","year":"2005","journal-title":"Technol. Cancer Res."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0600","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/1028415X.2017.1387721","article-title":"Short-term and long-term efficacy of classical ketogenic diet and modified Atkins diet in children and adolescents with epilepsy: a systematic review and meta-analysis","volume":"22","author":"Rezaei","year":"2019","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0605","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s13760-016-0601-x","article-title":"The effects of classic ketogenic diet on serum lipid profile in children with refractory seizures","volume":"116","author":"Zamani","year":"2016","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-7075-4-5","article-title":"The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer","volume":"4","author":"Zhou","year":"2007","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0615","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.semcancer.2017.12.011","article-title":"Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma","volume":"56","author":"Poff","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0620","article-title":"Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study","volume":"11","author":"van der Louw","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0625","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.3390\/nu11102497","article-title":"Ketogenic diet: a new light shining on old but gold biochemistry","volume":"11","author":"Longo","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-7075-10-47","article-title":"Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy","volume":"10","author":"Chang","year":"2013","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0635","first-page":"1","article-title":"Ketogenic diet for malignant gliomas: a review","author":"Thomas","year":"2020","journal-title":"Curr. Nutr. Rep."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0640","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/17425247.2016.1244187","article-title":"Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures","volume":"14","author":"Ragelle","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0645","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2217\/nnm.13.3","article-title":"Biotargeted nanomedicines for cancer: six tenets before you begin","volume":"8","author":"Goldberg","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0650","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1002\/cncr.21858","article-title":"Patterns of exercise across the cancer trajectory in brain tumor patients","volume":"106","author":"Jones","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0655","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.nicl.2018.02.021","article-title":"Repairing the brain with physical exercise: cortical thickness and brain volume increases in long-term pediatric brain tumor survivors in response to a structured exercise intervention","volume":"18","author":"Szulc-Lerch","year":"2018","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbmt.2021.11.003","article-title":"The effects of physical activity and exercise therapy on pediatric brain tumor survivors: a systematic review","volume":"30","author":"Khaleqi-Sohi","year":"2022","journal-title":"J. Bodyw. Mov. Ther."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0665","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fnmol.2016.00122","article-title":"Tumor metabolism, the ketogenic diet and \u03b2-hydroxybutyrate: novel approaches to adjuvant brain tumor therapy","volume":"9","author":"Woolf","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0670","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-15-0916","article-title":"A supplemented high-fat low-carbohydrate diet for the treatment of glioblastoma","volume":"22","author":"Martuscello","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0675","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/0973-1482.55134","article-title":"Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet","volume":"5","author":"Seyfried","year":"2009","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0680","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jconrel.2015.10.006","article-title":"Control of polymeric nanoparticle size to improve therapeutic delivery","volume":"219","author":"Hickey","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0685","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2217\/nnm-2018-0120","article-title":"Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities","volume":"14","author":"Farjadian","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.07.023_bb0690","doi-asserted-by":"crossref","DOI":"10.1088\/2053-1613\/aa5468","article-title":"Clinical and commercial translation of advanced polymeric nanoparticle systems: opportunities and material challenges","volume":"4","author":"Anselmo","year":"2017","journal-title":"Transl. Mater. Res."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0695","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cis.2007.04.021","article-title":"The nanoparticle\u2013protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century","volume":"134","author":"Lynch","year":"2007","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.jconrel.2022.07.023_bb0700","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2016.02.026","article-title":"Nanocarriers for the treatment of glioblastoma multiforme: current state-of-the-art","volume":"227","author":"Karim","year":"2016","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922004424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922004424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:32:26Z","timestamp":1759163546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922004424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":140,"alternative-id":["S0168365922004424"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.023","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymeric nanoparticles for drug delivery in glioblastoma: State of the art and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}